Beyond these cell division and signaling roles, CEP55 has recently been identified as an immunogenic tumor-associated antigen (TAA) and cancer-testis antigen (CTA), which recommend it as a potential candidate for cancer vaccine therapies. The gene discussed is CEP55; the disease is cancer.